ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FGN Futuragene

89.00
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futuragene LSE:FGN London Ordinary Share GB0031791782 ORD 0.5P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.00% 89.00 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
  -
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 89.00 GBX

Futuragene (FGN) Latest News

Real-Time news about Futuragene (London Stock Exchange): 0 recent articles

Futuragene (FGN) Discussions and Chat

Futuragene (FGN) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Futuragene (FGN) Top Chat Posts

Top Posts
Posted at 13/4/2010 18:12 by kooba
agree n_w_b could even be a few shorts closing as well,either way takeover talks ongoing at equivalent of then current share price which was 88p high 82p low on day of rns 23rd feb.todays price action perhaps indicating progress is being made, did hear mention that predator could be brazilian fwiw.
Posted at 13/4/2010 14:53 by someuwin
Worth repeating - Evolutions initial coverage of FGN from last october.

(Bear in mind that since October we have had news on...

poplar trees.

Cotton plants with Bayer.

Chinese patent for food and non food drought tolerance.

Japanese patent for cell wall modification.

Chinese licensing agreement for Cotton...)



FuturaGene (FGN.L) Buy

Trade of the decade

Relentless population growth is placing a severe strain on our agricultural
resources. By 2020 the world's forests and farms will have to provide
timber and food for 800m more people than they do today. The drive to
boost crop yields led to a twenty-fold increase in Monsanto's share price
in the last decade; we think similar trends will make FuturaGene a stellar
performer in the next.

Yield-enhancing technology for the forestry and biofuel sectors

FuturaGene's genetic technology can boost farm and forestry crop yields by
25-300%, depending on species. It can also accelerate growth, improve stress
tolerance and enhance productivity in paper and biofuel processing plants.

Billion-dollar customers in billion-dollar markets

The Top 10 wood-producing countries exported $100bn of forestry products in
2005, so a 25% yield increase would create more than $25bn of value a year.
Unsurprisingly, several major forestry and agricultural players have expressed
interest in FuturaGene's technology.

Suzano Papel e Celulose (EV $5bn), the world's No2 eucalyptus pulp producer, has
contracted to use FuturaGene's technology in its plantations. Suzano has
completed a successful three-year trial of FuturaGene's eucalyptus prototypes, and
is currently pursuing regulatory approval for commercial deployment.

FuturaGene is also working with: the largest supplier of alfalfa seeds in the US; a
leading developer and supplier of seedlings for China's forestry industry; a biotech
with access to the huge US corn market; one of Thailand's largest forestry
companies. If these partnerships progress to plan, we estimate they could
generate annual royalties worth tens of millions of dollars.

A hidden gem with huge potential

Although FuturaGene has made excellent progress with customers in recent
years, a legal dispute – now fully resolved – with the company's founders
prevented the current management from promoting the story to investors. We
now expect a more active approach to investor relations and positive newsflow
from the Suzano partnerships – and a significant boost to FuturaGene's profile.

Demographic trends suggest that the next decade will be extremely interesting
for FuturaGene and its shareholders. Wide adoption of FuturaGene's technology
could add billions of dollars to the annual output of the forestry and biofuel
industries. Even if FuturaGene captured only a tiny proportion of that value, its
profits would dwarf the company's current market cap of £25m. BUY.
Posted at 25/3/2010 13:56 by kooba
if they came out with a bid off now after the share price movement and volume would expect the board to be arrested let alone some of their shareholders!!
Posted at 25/3/2010 13:54 by someuwin
I think as far as the company is concerned, its business as usual.

The fact that Parvizi (amongst others) is being investigated for allegedlly being part of an insider dealing ring is nothing to do with FGN itself.

The share price fall has been a total overreaction imo.
Posted at 25/3/2010 11:41 by mf10
He only raised his holding on the 16th and gained nothing in terms of share price movement.

Even if the bid was 85p, it's a small profit.

Doubt the investor has anything to do with the deal talks or the company.

And of course, they're all claiming innocence!

Let's face it, people invest based on market rumours every other day and then the company puts out a statement to say that market speculation was correct.

Do they all get investigated for insider dealing?

Let's just say that it's not that easy to keep someone talking when talks are ongoing about possible deals and the FSA will have a very hard time proving anything having spent years and thousands of man hours to arrest 7 people!!
Posted at 25/3/2010 11:07 by robert_ainsworth
Wow, just had a look at that link posted earlier, to do with the FSA investigation. WIthout a doubt that has had a major impact upon theshare price, buti feel it was a huge over reaction. Typical nowadays, but not complaints from me. Its where the money is made. =)
Posted at 24/2/2010 09:05 by n_w_b
Agree...Just because a company gets a bid at a certain price, doesn't mean they're going to accept it. What it does do though is provide a floor for the share price.

It's got to be at least a premium to current Broker price targets. EVO's 100p target from October, which is before the deals that have been done recently, should be raised and say 20% extra as a starting point, for anyone to take a bid seriously.

I'm gutted, as I was in for the long term and wanted to benefit when all the revenue streams started coming in. Unfortunately all too often companies with massive potential and gobbled up by majors, before there allowed to become competitors.

However...it looks like our fate is going that way and as such I'd consider 130p if it were offered today.
Posted at 23/2/2010 16:37 by n_w_b
With FGN fully funded through through to it's first profits; why sell out at this level.

It's not like the share price has risen that much in the last couple of months; surely a significant premium or incentive is required, considering the huge potential.


Opportunist maybe?

I vote No!
Posted at 23/2/2010 10:58 by someuwin
For those that haven't seen it this is the introduction to Evolutions initial coverage of FGN last october.

(Bear in mind that since October we have had news on...

poplar trees.

Cotton plants with Bayer.

Chinese patent for food and non food drought tolerance.

Japanese patent for cell wall modification.

Chinese licensing agreement for Cotton...)




FuturaGene (FGN.L) Buy

Trade of the decade

Relentless population growth is placing a severe strain on our agricultural
resources. By 2020 the world's forests and farms will have to provide
timber and food for 800m more people than they do today. The drive to
boost crop yields led to a twenty-fold increase in Monsanto's share price
in the last decade; we think similar trends will make FuturaGene a stellar
performer in the next.

Yield-enhancing technology for the forestry and biofuel sectors

FuturaGene's genetic technology can boost farm and forestry crop yields by
25-300%, depending on species. It can also accelerate growth, improve stress
tolerance and enhance productivity in paper and biofuel processing plants.

Billion-dollar customers in billion-dollar markets

The Top 10 wood-producing countries exported $100bn of forestry products in
2005, so a 25% yield increase would create more than $25bn of value a year.
Unsurprisingly, several major forestry and agricultural players have expressed
interest in FuturaGene's technology.

Suzano Papel e Celulose (EV $5bn), the world's No2 eucalyptus pulp producer, has
contracted to use FuturaGene's technology in its plantations. Suzano has
completed a successful three-year trial of FuturaGene's eucalyptus prototypes, and
is currently pursuing regulatory approval for commercial deployment.

FuturaGene is also working with: the largest supplier of alfalfa seeds in the US; a
leading developer and supplier of seedlings for China's forestry industry; a biotech
with access to the huge US corn market; one of Thailand's largest forestry
companies. If these partnerships progress to plan, we estimate they could
generate annual royalties worth tens of millions of dollars.

A hidden gem with huge potential

Although FuturaGene has made excellent progress with customers in recent
years, a legal dispute – now fully resolved – with the company's founders
prevented the current management from promoting the story to investors. We
now expect a more active approach to investor relations and positive newsflow
from the Suzano partnerships – and a significant boost to FuturaGene's profile.

Demographic trends suggest that the next decade will be extremely interesting
for FuturaGene and its shareholders. Wide adoption of FuturaGene's technology
could add billions of dollars to the annual output of the forestry and biofuel
industries. Even if FuturaGene captured only a tiny proportion of that value, its
profits would dwarf the company's current market cap of £25m. BUY.
Posted at 06/2/2010 08:59 by n_w_b
Taken from this weeks Investors Chronicle's Cover story and main feature on Page 25 entitled "CASH IN ON CROPS"; FGN mentioned as a way of investing in the agricultural space.

It talks about the lack of land for agricultural food needs, due to the population increase and how GM could be used to solve the world food shortage to come in the future.

Samples taken from the article, well worth anybody picking up a copy for the full read, or subscribing to IC advantage to read.



'With global population growth placing ever-greater demands on the world's food supplies, agricultural investments could be an important store of value for your portfolio.'



...'Merrill Lynch has said it believes agricultural commodities are still in the early stages of a long term bull run'



...'US agribusiness giant Monsanto has the largest share of the GM crop market, but there are numerous agri-biotechs around the world, including the likes of Futuragene and Plant Health care, that offer UK equity exposure to this major trend. The ISAA expects adoption to rise sharply, and estimates that increased concerns over food security and the growing awareness of the environmental benefits of GM will see the number of biotech countries and plantings double by 2015 as new GM strains are introduced.

Mr Chandler(of Rabobank) says that GMO's are also being developed that allow crops to withstand even the more extreme weather conditions, such as drought or floods, that are usually responsible for supply shortages.'


The last paragraphs referring to one of our technologies, plus ours works in cold climates ;-)

The articles also mentions how land is being taken away from food producing, to producing Biofuels. Another one of our technologies.


Then on Page 48 of the IC they mention buying Sarasin Agrisar Fund. There's a list of the top 10 investments the fund has; no mention of FGN, although they have a 3.1% holding in Plant Heatlh Care that was mentioined with FGN in the other article as UK stocks to buy for exposure...maybe they'll be buying some FGN soon.IMHO

"The Agristar manager has direct access to the Food and Agribusiness Research team at Rabobank, Sarasin's parent company and the world's leading bank focused on the agricultural sector" So that links in nicely with the previous article with comments from Rabobank's Mr Chandler.



So where's the largest market in the world...China...and who's anouncing partnerships, patents and working with the forestry department ;-)


Then there's our Poplar and eucalyptus projects that are in trails in Brazil that make trees grow quicker and are more dense.

Very exciting times ahead, especially when the word gets out in the investment community.
Futuragene share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock